Novartis Awaits Invite To Bid On Aventis, Says Combination Is "Viable"
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis wants a formal invitation from the Aventis board and a "neutral position" by the French government before it enters into merger negotiations. Novartis believes there is a "business case" for the merger, which it envisions as a two-step transaction including a spin-off of "non-core" products.
You may also be interested in...
Sanofi Holds Line On Aventis Merger Price; Novartis Enters Talks
Sanofi will continue to evaluate the market reaction before deciding whether to sweeten its bid. Novartis accepts Aventis’ invitation to explore a deal; the move indicates France has expressed neutrality on an Aventis/Novartis combination.
Sanofi Holds Line On Aventis Merger Price; Novartis Enters Talks
Sanofi will continue to evaluate the market reaction before deciding whether to sweeten its bid. Novartis accepts Aventis’ invitation to explore a deal; the move indicates France has expressed neutrality on an Aventis/Novartis combination.
Aventis Sues To Block Sanofi Bid; Warns That “Synergies” Would Hit Hard In U.S.
New Jersey lawsuit notes that Sanofi projects significant savings from merger but is downplaying impact in France and Germany. Aventis continues no-holds-barred defense against Sanofi bid.